Editas Medicine director Akshay Vaishnaw resigns from Board effective June 30, 2024

Editas Medicine, Inc.

Akshay Vaishnaw submitted resignation on June 27, 2024; effective June 30, 2024.
Resignation not due to any disagreement with Company’s operations, policies, or practices.
No replacement or additional board changes announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Akshay Vaishnaw

Director

EDIT · Editas Medicine, Inc.

Effective: 2024-06-30
Filed: June 27, 2024, 7:59 PM ET

On June 27, 2024, Akshay Vaishnaw informed the Board of Directors (the “Board”) of Editas Medicine, Inc. (the “Company”) of his resignation from the Board effective as of June 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Akshay Vaishnaw resigned as Director at Editas Medicine, Inc..

Action: resigned
Role: Director

Exact text from the filing

On June 27, 2024, Akshay Vaishnaw informed the Board of Directors (the “Board”) of Editas Medicine, Inc. (the “Company”) of his resignation from the Board effective as of June 30, 2024.

View on SEC.gov

Editas Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001650664-24-000081

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.